Will the research administer a transcriptomic RNA viral load test for antisense RNA to discover who has Long Covid viral persistence, establish a baseline, &amp; measure efficacy during the trial? Or is this another symptom only study w/out SARS-CoV-2 RNA viral load biomedical data?